Sep 16, 2007
Baraclude is carcinogenic on Rodent with low doses according to ASSLD. Is this a concern for patient who starts treatment with baraclude. Tyzeka and hepsera do not seem to have have this issue. What is the drug preference for treating precore mutant HBV (e-antigen negative)? Is Tyzeka better since its profile regaring carcinogen is better?
Response from Dr. McGovern
Telbivudine (Tyzeka) is not carcinogenic in mice at doses up to 14 times that used in humans.
Adefovir is not carcinogenic in mice at doses up to 10 times that used in humans.
Entecavir (Baraclude) was shown to be carcinogenic in mice - but this was at 42 times the dose that is normally given to humans! These types of studies are done all the time in the pharmaceutical industry. These data are actually reassuring.
The bottom line is that all three drugs appear to be safe in the normal doses used in humans.
Thanks from Ur Reply
whats wrong with me?
- What Generation Of HIV Test Does The Military Use?
- Is It Against The Law To Have Sex With Someone And Not Tell Them That You Have Hiv?
- If I Have High White Blood Cell Count Does That Mean I Have Hiv?
- How Long After Exposure Does Hiv Rash Appear?
- What Are The Possibilities Of Getting Hep C From A Needle Prick?
- Vaginal Symptoms Of Hiv
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.